Healthcare & Medical Devices Global On demand · 24-48h

Global Automatic Blood Bag Tube Stripper Market Strategic Research Report

Global Automatic Blood Bag Tube Stripper Market Strategic Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Automatic Blood Bag Tube Stripper Market
$2672025
5.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Corded Electric, Cordless Battery-Operated, Hybrid

By Application: Blood Banks and Transfusion Centers, Hospitals and Surgical Theaters, Plasma Collection Facilities, Mobile Blood Donation Unit, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: LMB Technologie, REMI LAB WORLD, Sarstedt, Hettich, Conroy Medical, Bioline India, Mitra Industries, Fresenius Kabi, Laboid International, Jeshra Instruments, Genesis BPS, Krew Instruments, EMA, Insignia International

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 115 pages
Market size 2025
$267
Million USD
Forecast CAGR
5.6%
2025-2032
Forecast 2032
$391
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Automatic Blood Bag Tube Stripper market size is predicted to grow from US$ 267 million in 2025 to US$ 392 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.

An Automatic Blood Bag Tube Stripper is a precision medical device designed for non-destructive removal of undiluted blood from PVC donor tubing attached to blood bags, facilitating efficient transfer of blood contents for sampling, quality control, cross-matching, and anticoagulation processes in transfusion medicine. These battery or mains-powered devices use motorized roller systems to gently squeeze tubing, pushing blood into collection bags or sample tubes while preventing contamination, preserving blood component integrity, and reducing repetitive motion injuries for healthcare workers. Equipped with auto-stop functions at tube/bag couplings, they ensure complete stripping without damaging blood bags or tubing.

In 2025, global Automatic Blood Bag Tube Stripper production reached approximately 85,313 units, with an average global market price of around US$ 3,200 per unit. The production capacity of Automatic Blood Bag Tube Stripper is approximately 107 K units per year, the average gross profit margin was 28-31%.

The upstream supply chain for Automatic Blood Bag Tube Strippers consists of raw material providers (stainless steel for rollers, medical-grade plastics for housings, electric motors, lithium-ion batteries, electronic control components, and precision mechanical parts), followed by component manufacturers producing sub-assemblies (motor units, roller mechanisms, circuit boards). These components are then supplied to medical device manufacturers who integrate them into finished products, incorporating quality control systems, regulatory compliance testing (ISO 13485, FDA approval), and packaging. The downstream supply chain includes medical distributors, hospital group purchasing organizations (GPOs), and direct sales channels that deliver products to end-users: blood banks, transfusion centers, hospitals, plasma collection facilities, and mobile blood donation units. Aftermarket services (maintenance, repair, replacement parts) form the final link, supporting product longevity in clinical settings.

The cost structure of Automatic Blood Bag Tube Strippers is dominated by raw materials and components (55-65%), including stainless steel rollers (10-15%), high-torque medical-grade motors (15-20%), electronic control systems with sensors (10-15%), and durable plastic housings (5-10%). Manufacturing and assembly costs (15-20%) cover precision engineering, quality assurance testing, regulatory compliance documentation, and sterile packaging processes essential for medical devices. Research and development (5-8%) includes design improvements for ergonomics, battery life optimization, and auto-stop functionality enhancements. Marketing and distribution (8-12%) encompasses sales team salaries, trade show participation, medical distributor margins, and product training for healthcare staff. Overhead costs (5-7%) include administrative expenses, facility maintenance, and customer support services. Profit margins typically range from 35-45% for established manufacturers, reflecting the specialized nature of the product and regulatory barriers to entry.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Automatic Blood Bag Tube Stripper market?

What factors are driving Automatic Blood Bag Tube Stripper market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Automatic Blood Bag Tube Stripper market opportunities vary by end market size?

How does Automatic Blood Bag Tube Stripper break out by Type, by Application?

This report presents a comprehensive overview of the global Automatic Blood Bag Tube Stripper market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Corded Electric
  • Cordless Battery-Operated
  • Hybrid

Segment by Stripping Speed (mm/second)

  • Low-Speed (5-10 mm/s)
  • Medium-Speed (10-20 mm/s)
  • High-Speed (20-30 mm/s)

Segment by Application

  • Blood Banks and Transfusion Centers
  • Hospitals and Surgical Theaters
  • Plasma Collection Facilities
  • Mobile Blood Donation Unit
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Automatic Blood Bag Tube Stripper market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Blood Banks and Transfusion Centers, Hospitals and Surgical Theaters, Plasma Collection Facilities evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Automatic Blood Bag Tube Stripper Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$267
2025
Forecast
$391
2032
CAGR
5.6%
2025–2032
Régions
5
global
Key companies
LMB TechnologieREMI LAB WORLDSarstedtHettichConroy MedicalBioline IndiaMitra IndustriesFresenius Kabi
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Corded ElectricCordless Battery-OperatedHybrid
By Application
Blood Banks and Transfusion CentersHospitals and Surgical TheatersPlasma Collection FacilitiesMobile Blood Donation UnitOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Corded Electric
  • 3.1.3 Cordless Battery-Operated
  • 3.1.4 Hybrid
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Blood Banks and Transfusion Centers
  • 4.1.3 Hospitals and Surgical Theaters
  • 4.1.4 Plasma Collection Facilities
  • 4.1.5 Mobile Blood Donation Unit
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 LMB Technologie
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 REMI LAB WORLD
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Sarstedt
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Hettich
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Conroy Medical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Bioline India
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Mitra Industries
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Fresenius Kabi
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Laboid International
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Jeshra Instruments
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Genesis BPS
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Krew Instruments
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 EMA
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Insignia International
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Automatic Blood Bag Tube Stripper market size?
The global Automatic Blood Bag Tube Stripper market is estimated at US$ 267 million in 2025 (base year) and is projected to reach US$ 392 million by 2032.
What growth rate is expected for the Automatic Blood Bag Tube Stripper market through 2032?
The market is expected to grow at a CAGR of 5.6% from 2026 to 2032, expanding from US$ 267 million in 2025 to US$ 392 million in 2032, roughly 1.5 times its base-year value.
How is Automatic Blood Bag Tube Stripper defined?
An Automatic Blood Bag Tube Stripper is a precision medical device designed for non-destructive removal of undiluted blood from PVC donor tubing attached to blood bags, facilitating efficient transfer of blood contents for sampling, quality control, cross-matching, and anticoagulation processes in transfusion medicine. Equipped with auto-stop functions at tube/bag couplings, they ensure complete stripping without damaging blood bags or tubing.
What are the main segments of the Automatic Blood Bag Tube Stripper market by type?
By type, the market is segmented into Corded Electric, Cordless Battery-Operated and Hybrid.
Which applications drive demand in the Automatic Blood Bag Tube Stripper market?
Key applications covered include Blood Banks and Transfusion Centers, Hospitals and Surgical Theaters, Plasma Collection Facilities, Mobile Blood Donation Unit and Others.
Who are the key players in the Automatic Blood Bag Tube Stripper market?
Key players profiled include LMB Technologie, REMI LAB WORLD, Sarstedt, Hettich, Conroy Medical, Bioline India, Mitra Industries and Fresenius Kabi, among 14 companies covered in total.
Which regions and countries are covered for Automatic Blood Bag Tube Stripper?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Automatic Blood Bag Tube Stripper market?
What factors are driving Automatic Blood Bag Tube Stripper market growth, globally and by region?
What challenges does the Automatic Blood Bag Tube Stripper market face?
Profit margins typically range from 35-45% for established manufacturers, reflecting the specialized nature of the product and regulatory barriers to entry.
Who should buy the Automatic Blood Bag Tube Stripper market report?
The report is intended for manufacturers and solution providers, distributors and end users in Blood Banks and Transfusion Centers, Hospitals and Surgical Theaters and Plasma Collection Facilities, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Automatic Blood Bag Tube Stripper market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.